Development and validation of a next-generation sequencing (NGS)-based 24-chromosome aneuploidy screening system

      Many platforms are available for 24-chromosome embryonic aneuploidy screening, including qPCR, aCGH, and SNP arrays. NGS provides a new approach with potential advantages including reduced costs and enhanced precision. It allows parallel and customizable analysis of multiple embryos on one chip. This study details the validation of a cost-effective NGS methodology for 24-chromosome aneuploidy screening.
      To read this article in full you will need to make a payment


      Subscribe to Fertility and Sterility
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect